# OnCo record nct05261269 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05261269/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05261269", "NCT05261269" ;
  schema:name "A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer"@en ;
  schema:description "A phase 1 trial of DAN-222 run by Dantari, Inc., completed."@en ;
  schema:url <https://onco.cc/trials/nct05261269/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05261269> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/dan-222/> ;
  onco:companies <https://onco.cc/companies/dantari/> .